104 related articles for article (PubMed ID: 19754924)
21. Effect of paternal and maternal cancer on cancer in the offspring: a population-based study.
Hemminki K; Vaittinen P
Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):993-7. PubMed ID: 9419393
[TBL] [Abstract][Full Text] [Related]
22. Attributable risks of familial cancer from the Family-Cancer Database.
Hemminki K; Czene K
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1638-44. PubMed ID: 12496055
[TBL] [Abstract][Full Text] [Related]
23. A t(11;14)(p13;q11.2) in myelofibrosis following polycythemia vera.
Jeong JH; Ahn JY; Park PW; Seo YH; Seo JY; Lee JH; Kim KH
Cancer Genet; 2016 Mar; 209(3):112-6. PubMed ID: 26826764
[TBL] [Abstract][Full Text] [Related]
24. Familial risks in in situ cancers from the Family-Cancer Database.
Hemminki K; Vaittinen P
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):865-8. PubMed ID: 9796630
[TBL] [Abstract][Full Text] [Related]
25. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
[TBL] [Abstract][Full Text] [Related]
26. Familial risk for lung cancer by histology and age of onset: evidence for recessive inheritance.
Hemminki K; Li X
Exp Lung Res; 2005 Mar; 31(2):205-15. PubMed ID: 15824021
[TBL] [Abstract][Full Text] [Related]
27. Identification of JAK2V617F in patients with polycythemia is highly correlated with conventional criteria for diagnosis of polycythemia vera.
Ganly P; Hanrahan V; Baker B; Romeril K
Am J Hematol; 2007 Jan; 82(1):80-2. PubMed ID: 16924638
[TBL] [Abstract][Full Text] [Related]
28. Karyotype and molecular cytogenetic studies in polycythemia vera.
Andrieux JL; Demory JL
Curr Hematol Rep; 2005 May; 4(3):224-9. PubMed ID: 15865876
[TBL] [Abstract][Full Text] [Related]
29. Familial risk for colorectal cancers are mainly due to heritable causes.
Hemminki K; Chen B
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1253-6. PubMed ID: 15247139
[TBL] [Abstract][Full Text] [Related]
30. Familial association of colorectal adenocarcinoma with cancers at other sites.
Hemminki K; Chen B
Eur J Cancer; 2004 Nov; 40(16):2480-7. PubMed ID: 15519523
[TBL] [Abstract][Full Text] [Related]
31. [Agnogenic myeloid metaplasia and polycythemia vera in the same family].
Tosato F; Pirrone S; Manzo M; Diplotti L; Sponza E
Haematologica; 1985; 70(3):240-1. PubMed ID: 3932153
[No Abstract] [Full Text] [Related]
32. Modification of risk for subsequent cancer after female breast cancer by a family history of breast cancer.
Hemminki K; Zhang H; Sundquist J; Lorenzo Bermejo J
Breast Cancer Res Treat; 2008 Sep; 111(1):165-9. PubMed ID: 17899363
[TBL] [Abstract][Full Text] [Related]
33. Familial colorectal adenocarcinoma and hereditary nonpolyposis colorectal cancer: a nationwide epidemiological study from Sweden.
Hemminki K; Li X
Br J Cancer; 2001 Apr; 84(7):969-74. PubMed ID: 11286479
[TBL] [Abstract][Full Text] [Related]
34. [Fate of polycythemia vera treated by radioactive phosphorus. Apropos of a series of 303 patients followed for 12 to 24 years].
Tubiana M; Attie E; Parmentier C
Nouv Presse Med; 1975 Jun; 4(24):1781-6. PubMed ID: 1161478
[TBL] [Abstract][Full Text] [Related]
35. [The risk factors for thrombosis, myelofibrosis and leukemia transformation in patients with polycythemia vera].
Bai J; Xue YP; Ye L; Yao JF; Zhou CL; Qian LS; Yang RC; Li HY; Zhang HY; Shao ZH
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):685-8. PubMed ID: 18399175
[TBL] [Abstract][Full Text] [Related]
36. [Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the Polycythemia vera patients].
Dombi P; Illés Á; Demeter J; Homor L; Simon Z; Kellner Á; Karádi É; Valasinyószki E; Udvardy M; Egyed M
Orv Hetil; 2017 Jun; 158(23):901-909. PubMed ID: 28580853
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemia vera and idiopathic myelofibrosis.
Kutti J; Ridell B
Pathol Biol (Paris); 2001 Mar; 49(2):164-6. PubMed ID: 11317963
[TBL] [Abstract][Full Text] [Related]
38. Do discordant cancers share familial susceptibility?
Hemminki K; Sundquist J; Brandt A
Eur J Cancer; 2012 May; 48(8):1200-7. PubMed ID: 22033325
[TBL] [Abstract][Full Text] [Related]
39. Higher risk of primary cancers after polycythaemia vera and vice versa.
Fallah M; Kharazmi E; Sundquist J; Hemminki K
Br J Haematol; 2011 Apr; 153(2):283-5. PubMed ID: 21275965
[No Abstract] [Full Text] [Related]
40. Concordant and discordant familial cancer: Familial risks, proportions and population impact.
Frank C; Sundquist J; Yu H; Hemminki A; Hemminki K
Int J Cancer; 2017 Apr; 140(7):1510-1516. PubMed ID: 28006863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
